Baidu
map

广东药店将分级 级别不够不可销售处方药

2018-04-12 陈泽云、石耀轩 金羊网

4月11日,广东省食药监局召开新闻通气会,解读加强药品零售企业管理的规范性文件。据介绍,广东将推行药店“分级分类”管理制度,零售药店将分为一类店、二类店和三类店进行管理。其中,一类店只能经营非处方药,二类店可以经营处方药,但不能经营中药饮片,三类店则可以销售非处方药、处方药、中药饮片等所有可在药品零售企业销售的药品。该办法将于4月15日起实施。明确三类药店经营范围据介绍,一类店经营范围限定为非处

4月11日,广东省食药监局召开新闻通气会,解读加强药品零售企业管理的规范性文件。据介绍,广东将推行药店“分级分类”管理制度,零售药店将分为一类店、二类店和三类店进行管理。其中,一类店只能经营非处方药,二类店可以经营处方药,但不能经营中药饮片,三类店则可以销售非处方药、处方药、中药饮片等所有可在药品零售企业销售的药品。该办法将于4月15日起实施。

明确三类药店经营范围

据介绍,一类店经营范围限定为非处方药。二类店经营范围限定为非处方药、处方药(注射剂、肿瘤治疗药、抗生素、生物制品、二类精神药品、医疗用毒性药品、罂粟壳、中药饮片等除外)。三类店经营范围包括非处方药、处方药、中药饮片等所有可在药品零售企业销售的药品。经批准三类店还可销售二类精神药品、医疗用毒性药品及罂粟壳,并在《药品经营许可证》的经营范围上单独列明。

值得注意的是,上述企业均禁止销售麻醉药品、放射性药品、第一类精神药品、终止妊娠药品、蛋白同化制剂、肽类激素(胰岛素除外)、药品类易制毒化学品、疫苗等法律法规的规定。

此外,药品零售企业将按风险程度从小到大依次分为A级、B级、C级和D级,并根据日常监督检查、跟踪检查及飞行检查结果,结合设置条件的满足程度进行动态调整,并规定从高级别调整至低级别后,再调整至高级别的,时间间隔不能少于一年。

提高药学技术人才配备

按照规定,药品零售企业应配备足够的、与经营范围和经营规模及岗位职能相适应的药学技术人员,从事质量管理、药学服务及处方审核等工作。企业按照国家有关规定配备的执业药师,负责处方审核,指导合理用药,并对经其审核的处方负责。

数据显示,截至2016年,广东省零售药店数量为52137家,仍居全国第一,而执业医师注册数量为14381人,配备率为26.30%,缺口高达3万多人。

对此,省食药监局药品流通安全监督处处长林奇艺表示,根据相关管理办法和广东实际情况,调整了中药经营执业药师配备。其中,一类店可不配备执业药师,但至少配备1名药学技术人员,而三类店则至少需要配备1名执业药师和2名药师或以上职称的药学技术人才,如经营中药饮片,则需要1名执业中药师或中药师。“这在一定程度上也缓和了执业药师的短缺,给予中小零售药店生存空间。”

据介绍,推行药品零售企业分级分类管理,可更好针对性管理,从而更好满足广大人民群众的用药需求,确保药品质量安全。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1687307, encodeId=e396168e307c4, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Fri Feb 15 23:18:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345941, encodeId=1d18134594158, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Apr 14 12:18:00 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305179, encodeId=c56e3051e9df, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Apr 12 21:54:16 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305172, encodeId=13253051e2f2, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu Apr 12 21:53:12 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305167, encodeId=923330516ea8, content=加強药店管理.保障用药安全., beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Apr 12 21:28:24 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1687307, encodeId=e396168e307c4, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Fri Feb 15 23:18:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345941, encodeId=1d18134594158, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Apr 14 12:18:00 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305179, encodeId=c56e3051e9df, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Apr 12 21:54:16 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305172, encodeId=13253051e2f2, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu Apr 12 21:53:12 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305167, encodeId=923330516ea8, content=加強药店管理.保障用药安全., beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Apr 12 21:28:24 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1687307, encodeId=e396168e307c4, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Fri Feb 15 23:18:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345941, encodeId=1d18134594158, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Apr 14 12:18:00 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305179, encodeId=c56e3051e9df, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Apr 12 21:54:16 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305172, encodeId=13253051e2f2, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu Apr 12 21:53:12 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305167, encodeId=923330516ea8, content=加強药店管理.保障用药安全., beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Apr 12 21:28:24 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
    2018-04-12 惠映实验室

    学习了.谢谢分享.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1687307, encodeId=e396168e307c4, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Fri Feb 15 23:18:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345941, encodeId=1d18134594158, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Apr 14 12:18:00 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305179, encodeId=c56e3051e9df, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Apr 12 21:54:16 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305172, encodeId=13253051e2f2, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu Apr 12 21:53:12 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305167, encodeId=923330516ea8, content=加強药店管理.保障用药安全., beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Apr 12 21:28:24 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
    2018-04-12 天地飞扬

    了解一下.谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1687307, encodeId=e396168e307c4, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Fri Feb 15 23:18:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345941, encodeId=1d18134594158, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Apr 14 12:18:00 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305179, encodeId=c56e3051e9df, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Apr 12 21:54:16 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305172, encodeId=13253051e2f2, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Thu Apr 12 21:53:12 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305167, encodeId=923330516ea8, content=加強药店管理.保障用药安全., beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Apr 12 21:28:24 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
    2018-04-12 1e0f8808m18(暂无匿称)

    加強药店管理.保障用药安全.

    0

相关资讯

海南一心堂药店被曝违规刷医保卡 官方承认属实

近日,据央视财经频道《经济半小时》报道称,三亚市“一心堂”连锁药店出现医保卡当消费卡购买非药品,以及开具虚假名称发票,涉嫌套取社保资金的情况。一心堂(标清)视频来源:央视财经随后,一心堂发布公告称,经媒体报道后,一心堂已成立调查组对此事进行调查,经调查,公司旗下全资子公司海南鸿翔一心堂医药连锁有限公司涉嫌违规刷医保卡一事属实。公告称,公司所属海南一心堂门店存在违规让顾客使用医保卡,支付个人医保允许

食药总局发文:重点抽查药店保健品

4月2日,国家食品药品监督管理总局发布了《关于印发食品及保健食品专项抽检监测工作方案的通知 》(以下简称《通知》),要求各省市药监对食品及保健食品组织专项抽检监测工作,重点检测农村、乡镇、城乡结合部等地区,零售药店也被列入其中。

大地震,大批药店不能卖处方药!

零售药店行业大洗牌即将开始,比取消GSP认证影响更大。一大批药店将不能再卖处方药。

药店也能开处方?成都试点药店内远程问诊

4日,成都高新区天久南巷一药店,市民李先生因咳嗽不止前来买药。“老毛病了,肯定有炎症,但家里的消炎药吃完了。”按照规定,李先生说的头孢克洛胶囊属处方药,只有凭处方才能买到。两难之下,李先生只能求助于药店的“微问诊”系统。很快,通过“微问诊”可视设备,成都东升医院医生王娇诊断李先生患急性支气管炎,在确定无过敏史后,王医生为其开了一张电子处方:“头孢克洛胶囊,2盒;清肺止咳丸,1盒。”这张电子处方随即

2018年零售药店处方药市场前瞻

2017年是医改关键的一年,政策频出:仅国家级发布的医改相关政策文件就已超300余份,主要涉及医药、医疗、医保和流通四大块。每项政策都对医药行业发展起着重要的影响。受医改相关政策及医保“控费”的影响,2017年处方药市场依然呈增速下滑的趋势。根据中康CMH研究数据分析,目前预测2017年处方药的主要渠道还会是医院渠道,但是院外终端用药的增长率会高于院内用药。依据医药分业的大趋势,再结合院内药品

Baidu
map
Baidu
map
Baidu
map